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ABSTRACT 
 
Ammonium, stemming from renal ammoniagenesis, is a major urinary proton buffer 
and is excreted along the collecting duct. This process depends on the concomitant 
secretion of ammonia (NH3) by the NH3 channel RhCG and of protons (H+) by the 
vacuolar-type H+-ATPase pump. Thus, urinary ammonium content and urinary 
acidification are tightly linked. However, mice lacking Rhcg excrete more alkaline 
urine despite lower urinary ammonium, suggesting an unexpected role of Rhcg in 
urinary acidification.  
RhCG and the B1 and B2 H+-ATPase subunits could be coimmunoprecipitated from 
kidney. In ex vivo microperfused cortical collecting ducts (CCD) H+-ATPase activity 
was drastically reduced in the absence of Rhcg. Conversely, overexpression of 
RhCG in HEK293 cells resulted in higher H+ secretion rates and increased B1 H+-
ATPase mRNA expression. However, in kidneys from Rhcg-/- mice the expression of 
only B1 and B2 subunits was altered. Immunolocalization of H+-ATPase subunits 
together with immuno-gold detection of the A H+-ATPase subunit showed similar 
localization and density of staining in kidneys from Rhcg+/+ and Rhcg-/-mice. In order 
to test also for a reciprocal effect of intercalated cell H+-ATPases on Rhcg activity, we 
assessed Rhcg and H+ATPase activities in mCCD from ATP6v1B1-/- mice and 
showed reduced H+-ATPase activity without altering Rhcg activity.  
Thus, RhCG and H+-ATPase are located within the same cellular protein complex. 
RhCG may modulate H+-ATPase function and urinary acidification, whereas H+-
ATPase activity does not affect RhCG function. This mechanism may help to 
coordinate NH3 and H+ secretion beyond the physico-chemical driving forces. 
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INTRODUCTION 
 
The renal collecting duct excretes acid into urine by parallel secretion of 
protons (H+) and ammonia (NH3) by vacuolar H+-ATPases (H+-ATPase) and the 
ammonia transporter RhCG 1-3. Renal acid excretion is critical for maintaining normal 
acid-base homeostasis and is increased during acidosis or following a systemic acid-
load 2. 
Highly conserved through evolution from bacteria to humans, RhCG belongs 
to the Rh (Rhesus) glycoprotein family and has been characterized by in vitro and ex 
vivo studies as a channel selectively permeable to NH3 but not to ammonium (NH4+) 
4-6. In the kidney, RhCG expression specifically spreads from the late distal 
convoluted tubule (DCT) to the inner medullary collecting duct (IMCD), on both 
basolateral and apical poles of most epithelial cells (with the exception of selective 
apical expression in non-type A intercalated cells) 7-11. We recently showed that 
RhCG is responsible for a major part of NH3 transported through apical and 
basolateral membranes of the collecting duct resulting in a drastic reduction of 
transepithelial NH3 transport in collecting ducts from Rhcg-/- mice 11-12. As a 
consequence of this defect, chronically acid-loaded Rhcg-/- mice cannot eliminate 
NH4+ into urine and develop a severe incomplete distal renal tubular acidosis (dRTA) 
characterized by low blood pH and HCO3- concentration 11-12. Similarly, mice with 
selective deletion of Rhcg from only the collecting duct or intercalated cells show 
reduced urinary ammonium excretion 13-14. 
While RhCG is responsible for luminal NH3 secretion, the renal H+-ATPase is 
critical to actively secrete H+ into urine 15-16. H+-ATPases are ubiquitous multi-
subunits proteins composed of a cytosolic V1 catalytic domain, responsible for ATP 
hydrolysis and a membrane-associated V0 domain mediating H+ translocation 16-17. In 
the collecting duct, H+-ATPases are localized at the luminal side of type-A 
intercalated cells and basolateral side of non-type A intercalated cells. The V1 domain 
contains 8 subunits A-H including the tissue-specific subunit isoforms B1 and B2. The 
B1 isoform is highly enriched in intercalated cells of kidney and its genetic mutation 
or deletion cause a form of distal renal tubular acidosis 18-20. The V0 domain contains 
6 different subunits, a, d, c, c', c", and e including a1, a2, a3 and a4. Also, the a4 
isoform is highly expressed in kidney 21-22 and mutations in human and its deletion in 
mice are associated with renal tubular acidosis 23-25.  
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Urinary acidification and ammonium content are closely linked26. Secretion of 
NH3 and H+ by RhCG and H+-ATPases may be coordinated since protonation of NH3 
and subsequent trapping of NH4+ are critical for the efficient excretion of NH4+ 26-29. 
The partial overlap of both proteins in type-A intercalated cells may allow even for a 
direct functional coupling or interaction30. We have recently shown in two differently 
constructed mouse models lacking Rhcg that urinary pH is more alkaline during 
stimulation of urinary acidification and NH4+ excretion 11-12. Since Rhcg-/- mice have 
highly reduced NH3 secretion, the lack of NH3 buffering capacity would be expected 
to result in a rather more acidic urinary pH, as shown in another mouse model with 
intact Rhcg-mediated NH3 secretion but reduced medullary NH4+ accumulation 31. 
Thus, we hypothesized that the absence of Rhcg may reduce proton secretion by H+-
ATPases. 
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RESULTS 
 
Rhcg and B1 and B2 subunits of H+-ATPase are part of one protein complex in native 
kidney 
 
 To assess whether RhCG and H+-ATPase were located within the same 
cellular protein complex in intercalated cells we performed coimmunoprecipitation of 
RhCG and  B1 and B2 H+-ATPase subunits from native rat kidney medulla (Figure 1). 
Immunoprecipitation with antibodies against RhCG or B1 (panel A and B) or RhCG or 
B2 (panel C and D) after chemical crosslinking yielded protein complexes that 
contained both proteins whereas immunoprecipitation with control IgG did not detect 
RhCG or the B subunits. Thus, RhCG, B1 and B2 containing H+-ATPases are part of 
the same protein complex in kidney. 
 We further confirmed partial colocalization of Rhcg and B1 subunits at the 
apical pole of intercalated cells in mouse kidney by immunohistochemistry (Figure 1, 
panel E). 
 
Rhcg-/- mice show a reduced capacity to excrete H+ from kidney CCD cells 
 We recently showed in ex vivo microperfused collecting ducts from Rhcg-/- 
mice a reduced NH3 transepithelial flux due to decrease in apical and basolateral NH3 
permeabilities 11-12. Here, using the same approach, we assessed H+ transport 
activity in microperfused CCDs from Rhcg+/+ and Rhcg-/- mice challenged for 2 days 
with an HCl load in food to maximize transport activities. Luminal NH4Cl prepulses 
were performed and H+ transport activity was assessed from the steep pHi recovery 
rates after maximal intracellular acidification when NH4Cl was removed from the 
lumen 32-33. The initial steep rate of alkalinisation reflects H+ extrusion, mostly by H+-
ATPases 33 (Figures 2A and 2B). We also observed in WT mice an early, almost 
immediate but slow pHi recovery which was not observed in KO mice suggesting that 
it is related to the function of Rhcg. As the initial pHi values were slightly different in 
CCDs from Rhcg-/- and Rhcg+/+ mice, we also measured intracellular buffering power 
and calculated H+ fluxes (JH+) across the membrane to directly compare transport 
rates. Similar to pHi recovery rates, JH+ was greatly reduced in CCDs from Rhcg-/- by 
89% (Rhcg+/+: 32.6 ± 12.8 pmol/mm/min vs. Rhcg-/-: 3.6 ± 0.63 pmol/mm/min, p ≤ 
0.0001) (Figure 2C). Thus, the more alkaline urine observed in Rhcg-/- during acid-
loading results from impaired proton secretion along the collecting duct. 
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The absence of Rhcg alters B1 and B2-H+-ATPase subunits expression 
 Next, we investigated whether the reduced H+ flux observed in microperfused 
CCDs from Rhcg-/- mice could be linked to altered expression of H+-ATPase subunits. 
At the mRNA level, we could not detect any variation of the intercalated cell-enriched 
B1 H+-ATPase isoform (suppl. figure 1A), and the more ubiquitous B2 (suppl. Figure 
1B) and a4 (suppl. Figure 1C) H+-ATPase isoforms between Rhcg+/+ and -/- mice. In 
membrane fractions from medullary kidney tissue to enrich the proportion of H+-
ATPases originating from intercalated cells, the amount of the intercalated cell 
specific B1 isoform (Figure 3A) was increased whereas the B2 isoform (Figure 3B) 
was decreased in kidney tissue from Rhcg-/- mice (p≤ 0.01). However, the protein 
abundance of the ubiquitous E2 (Figure 3C) and a1 isoforms (Figure 3D) as well as 
the kidney-enriched a4 (Figure 3E) subunits of the H+-ATPase was not different 
between the 2 genotypes.  
 
Rhcg does not regulate H+-ATPase localization 
 Reduced H+-ATPase activity may result from altered subcellular localization of 
H+-ATPases. Immunostaining for the B1, B2, E and a4 H+-ATPase subunits showed 
no apparent difference in subcellular localization of the 3 proteins in type-A 
intercalated cells in Rhcg+/+ and Rhcg-/- kidneys (Figure 4 and suppl. Figure 2). 
Electron microscopy with immunogold staining for the ubiquitious A subunit similarly 
detected no difference in the subcellular localization of this H+-ATPase subunit 
(Figure 5). The absence of Rhcg did not affect the immunoreactivity for the A subunit 
in type-A intercalated cells of Rhcg-/- mice. H+-ATPase staining was observed mostly 
in intercalated cells and was associated with the luminal membrane as well as with 
intracellular vesicles as described previously 16. Thus, the absence of Rhcg is not 
associated with a redistribution of H+-ATPases in type-A intercalated cells.  
 
The overexpression of RhCG in HEK293 cells increases H+ secretion rates 
 To test if the expression of RhCG was associated with stimulation of H+-
ATPase activity, we used HEK293 cells, which express H+-ATPases and exhibit H+-
ATPase-mediated H+ secretion across the plasma membrane 34. Non-transfected 
HEK293 cells and HEK293 cells stably transfected with human RhCG were used to 
examine the effect of RhCG expression on H+-ATPase expression and activity. qRT-
PCR confirmed high expression levels of RhCG in RhCG-transfected HEK293 cells 
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as reported previously (Figure 6A) 5. Next, we compared the expression levels of 
transcripts encoding different subunits of H+-ATPase, ATP6V1B1, ATP6V1B2 and 
ATP6V0A1, and found an exclusive increase in mRNA expression of ATP6V1B1 in 
HEK-RhCG compared to HEK-WT cells (Figure 6B-D). 
Following NH4Cl prepulse acidification in a HCO3- and Na+ free solution, we 
measured intracellullar pH recovery rates, similar to experiments in microperfused 
CCDs (Figure 7A). We have previously demonstrated that this pHi recovery is 
mediated solely by H+-ATPases and sensitive to the H+-ATPase blocker bafilomycin 
34. The initial pHi of both groups of cells measured was in the same range (pH 7.16 ± 
0.001 for non-transfected HEK293 cells and pH 7.18 ± 0.002 for RhCG expressing 
RhCG cells, Figure 7A) which allowed a direct comparison of ΔpHi/Δt. In HEK-RhCG 
cells, the rate of pHi-recovery after NH4Cl removal was 52 % higher than the one 
observed in non-transfected HEK (HEK-RhCG: (0.666 ± 0.001)*10-3 pH units/min vs. 
non-transfected HEK: (0.322 ± 0.006)*10-3 pH units/min, p≤ 0.01) (Figure 7B). This 
result suggests that the presence of RhCG can stimulate H+ secretion and is in 
agreement with our data showing that H+ secretion is impaired in collecting ducts 
from Rhcg-/- mice.  
 
Lack of the Atp6v1b1 H+-ATPase subunit reduces H+-ATPase activity without effect 
on NH3 permeability 
In order to assess whether H+-ATPase activity could affect Rhcg activity, we used a 
genetic animal model with reduced H+-ATPase activity, mice lacking the Atp6v1b1 
(B1) subunit 19, 35-36. Atp6v1b11-/- mice challenged with a HCl containing diet showed 
a more alkaline urinary pH compared to Atp6v1b1+/+ mice (Figure 8A and 
Supplementary table 1) as demonstrated previously19. However, urinary NH4+ 
excretion was similar between both genotypes before and during acute HCl 
treatment. But, after 4 days of acid inducing diet, Atp6v1b1-/- presented with a 
significant 23% reduction of NH4+ excretion (Figure 8B). To assess whether collecting 
ducts from Atp6v1b11-/- mice had altered NH3 permeability, we investigated NH3 
membrane permeabilities and H+ secretion in ex vivo microperfused isolated CCDs 
from Atp6v1b1+/+ and -/- mice receiving HCl diet for 2 days. We confirmed the 
expected reduction in H+ secretion in Atp6v1b1-/- mice (Figure 8C) but did not detect 
any differences in NH3 membrane permeability across the apical (Figure 8D) or 
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basolateral (Figure 89E) membranes. Thus, in this genetic model, reduced H+-
ATPase activity is not paralleled by reduced NH3 permeability.  
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DISCUSSION 
 
 The present study provides a new and additional explanation for the well-
known association between urinary acidification and ammonium excretion 26. We 
demonstrate that the ammonia channel RhCG is required for maximal urinary 
acidification and that RhCG stimulates H+-ATPase activity. 
Secretion of protons acidifies urine which provides a major driving force for NH3 
secretion and trapping of NH4+ after protonation. Thus, in this physico-chemical 
model, H+-secretion is the primary process which then affects the chemical gradient 
for NH3 secretion.  
 Urinary acidification depends on H+ excretion along the collecting duct 
mediated mostly by H+-ATPases and to a lesser extent by H+-K+-ATPases. In 
intercalated cells, H+-ATPases are the primary pump at the apical membrane 
mediating type A intercalated cell H+-excretion after an intracellular acid-load 33, 37. 
The B1 H+-ATPase subunit is specifically represented and colocalizes with RhCG at 
the luminal side of renal type A intercalated cells 10. Based on previous observations 
that Rhcg null mice had more alkaline urine despite reduced NH3 secretion rates 11-12, 
we hypothesized that Rhcg was required for maximal urinary acidification. Here, we 
observed a reduced apical H+ secretion rate in acid-loaded Rhcg-/- mice suggesting a 
form of regulation of H+-ATPases by RhCG or its activity.  
 In Rhcg-/- mice, reduced H+-ATPase activity was not caused by down-
regulation of B1 or other H+-ATPase subunits at mRNA or protein level. On the 
contrary, B1 was upregulated which may represent a compensatory process. The B2 
H+-ATPase subunit was downregulated and as previously been shown to exhibit 
counterregulation in B1 deficient mice 38. These data suggest that the reduction in 
apical H+ flux observed in Rhcg-/- mice CDs is not the consequence of a lower 
amount of H+-ATPases formed but rather explained by H+-ATPases which are not 
fully functional due to either an inadequate assembling of the subunits or improper 
insertion of the pumps at the plasma membrane. Immunohistochemistry and 
immunogold staining for several subunits of the V1 and V0 domains of the H+-ATPase 
at the apical pole of intercalated cells did not find any evidence for altered subcellular 
localization and the presence of both V0 and V1 domain subunits suggests also intact 
assembly of pumps. 
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 In vitro studies in HEK293 cells revealed that overexpression of RhCG 
stimulates H+ extrusion paralleled by higher mRNA expression of the B1 H+-ATPase 
subunit. HEK293 cells express H+-ATPases and exhibit H+ extrusion only after 
intracellular acidification in a slow, time dependent manner that is independent from 
trafficking of H+-ATPases to the plasma membrane 34. Thus, H+-ATPase activity is 
increased in the presence of RhCG in vivo and in vitro and this effect may involve 
also increased abundance of some subunits, at least in vitro.  
 
 We next tested in Atp6v1b1-/- mice whether H+ATPases would have a 
reciprocal regulatory effect on Rhcg activity. As previously reported, we observed 
higher urinary pH and highly reduced apical H+ transport in acute and chronic HCl 
acid-loaded Atp6v1b1-/- mice compared to wildtype littermates 19, 35-36. However, the 
absence of Atp6v1b1 and reduced H+-ATPase activity did not affect the NH3 
transport measured on both basolateral and apical cellular membranes. Accordingly, 
urinary NH4+ excretion was not different in 2 days acid-loaded Atp6v1b1-/- compared 
to wildtype. However, only after a more chronic acid-load, urinary NH4+ excretion was  
reduced in Atp6v1b1-/- mice compared to Atp6v1b1+/+ animals but to a much smalleri 
extent than in Rhcg-/- mice under the same conditions 11. The modest decrease in 
urinary NH4+ excretion could be due to the more alkaline urinary pH reducing the 
driving force for NH4+ secretion along the collecting system. Thus, RhCG stimulates 
H+-ATPase activity whereas reduced H+-ATPase activity does not directly impact on 
RhCG activity.  
 H+-ATPase activity is regulated by assembly/disassembly of the pump, 
trafficking to and from the membrane, and by phosphorylation at different sites which 
may occur in response to changes in acid-base status and/or endocrine factors 3, 15, 
39-51. RhCG may modulate H+-ATPase activity through at least two different 
mechanisms. NH3 stimulates H+/K+-ATPase possibly involving increased insertion of 
the H+/K+-ATPase via a SNARE-dependent process 52. RhCG participates in 
basolateral NH3 uptake 11 and loss of RhCG activity may reduce intracellular NH3 
levels and NH3 dependent regulation of luminal H+-extrusion. Alternatively, RhCG 
may stimulate H+-ATPase activity through (in)direct protein-protein interactions. The 
B1 H+-ATPase subunit possesses a PDZ domain to interact with other proteins 46. 
Whether RhCG interacts with other protein has not been reported to date. However, 
the related RhBG protein,  expressed at the basolateral side of renal CCD cells 53, 
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has been shown to be anchored to the membrane via the actin cytoskeleton-binding 
protein ankyrin-G 54 and to be part of a structural complex where the anion 
exchanger 1 (AE1) responsible for the secretion of HCO3- into blood by the 
intercalated cells can bind to both RhBG and ankyrin-G 55. This complex is essential 
for the activity of RhBG and AE1..Likewise, H+-ATPases exhibit interactions with the 
actin cytoskeleton, via the C subunit 56 and most likely via binding sites for F-actin 
that are present in the amino-terminal domains of both B1 and B2 isoforms 57 Thus, 
RhCG and H+-ATPases may be held together in one protein complex through 
interactions via the actin cytoskeleton. There is emerging evidence for large protein 
complexes involved in the regulation of H+-ATPases as well as coordinating the 
development of intercalated cells. These processes are critical for the kidneys ability 
to maintain and adapt acid excretion. On the one hand, rare mutations may exist in 
some patients and their discovery will help to diagnose hitherto unexplained cases of 
inborn dRTA. On the other hand, dysregulation of these networks may contribute to 
reduce acid excretion observed in patients with more common forms of CKD. 
Nevertheless, a better understanding of the components of these networks is 
required. 
 
 In summary, we show that RhCG and H+ATPases are located within the same 
cellular protein complex in the kidney and this interaction is required for maximal 
urinary acidification by H+-ATPases, a prerequisite for efficient NH3 secretion and 
urine excretion of NH4+. Thus, this novel mechanism provides a molecular 
explanation for the tight association between urinary acidification and ammonium 
excretion where RhCG mediates NH3 secretion and maximizes H+-secretion.  
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MATERIALS AND METHODS 
 
Co-Immunoprecipitation 
 Co-immunoprecipitation was performed using the Pierce Cross-link Magnetic 
beads kit (Pierce, USA) according to the manufacturers’ instructions. Fifty mg of 
medulla from rat kidney were homogenized using an electric homogenizer in 3 ml  
 Pierce IP Lysis/Wash Buffer (pH 7.4, 0.025M Tris, 0.15M NaCl, 0.001M EDTA, 1% 
NP40, 5% glycerol). Rabbit anti-B1 H+-ATPase 33 and rabbit anti-Rhcg (Proteintech, 
USA) polyclonal antibodies were bound to Pierce Protein A/G Magnetic Beads, and 
crosslinked using DSS reagent. Finally, crosslinked complexes were eluated with the 
pH 2.0 Pierce Elution Buffer, and neutralized with the Pierce Neutralization Buffer at 
pH 8.5. 
 
Animals - Rhcg+/+ and -/- mice were generated and bred as described before 11. Also, 
Atp6v1b1+/+ and -/- mice were bred as described before 19, 35. Mice were genotyped by 
PCR directly on a 3 µl 25 mM NaOH biopsy digestion product. 
Genomic DNA was amplified using primer pairs specific for Rhcg exon 1: forward 
(AGACCCCACAATGGAAAGCTATAA) and wildtype reverse 
(CAACCAGAACTCCCCAGTGTCAGA) and knock-out reverse 
(ATGGGCTGACCGCTTCCTCGTGCTTTAC) and Atp6v1b1 primer pairs specific for 
the Neo cassette: forward (CACGACGAGATCCTCGCCGTC) and reverse 
(GCGCAGCTAGTGCTCGACGTTG) and an Atp6v1b1 3′ flanking sequence not 
included within the targeting vector: forward (CTGGCACTGACCACGGCTGAG) and 
reverse (CCAGCCTGTGACTGAGCCCTG). The products were separated by 
electrophoresis on 1% agarose gels (Rhcg mutant product: 522 bp, wildtype product: 
376 bp, Atp6v1b1 mutant product: 300 bp, wildtype product: 200bp). 
All animal experiments were performed in acid-loading conditions for which mice 
were given 0.2 M HCl added to powdered standard food for 2 days. All experiments 
were performed according to Swiss Animal Welfare laws and were approved by the 
local veterinary authority (Veterinäramt Zürich). 
 
In vivo experiments 
 All experiments were performed using age- and sex-matched Atp6v1b1 
wildtype (Atp6v1b1+/+) and Atp6v1b1 knockout (Atp6v1b1-/-) littermate mice (3-4 
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month-old), housed in metabolic cages (Techniplast, Switzerland). Mice were given 
deionized water ad libitum and were fed with a standard powdered laboratory chow 
(Kliba, Augst, Switzerland). Mice were allowed to adapt to metabolic cages for 3 days 
and a first retro-orbital blood sample was taken for blood gas analysis at baseline. 
Then, two 24 hrs urine samples were collected under light mineral oil in the urine 
collector to determine daily urinary parameters. Mice were then allowed to recover for 
2 weeks before given a HCl-containing diet (0.2 M HCl added to powdered standard 
food) in normal cages. Food, water intake, and urine excretion was monitored 
following the same procedures as under baseline conditions. Urine collections were 
performed on the first, second and fourth day of acid-loading. Retro-orbital blood 
samples were taken on the second and fourth day of the HCl diet under light 
anesthesia with isoflurane. All animal experiments were conducted according to 
Swiss Laws of Animal Welfare and approved by the local Zurich Veterinary Authority 
(Kantonales Veterinäramt Zürich). 
 
 
Analytic procedures 
 Blood pH, pCO2, and electrolytes were measured with a pH/blood-gas 
analyzer (ABL77 Radiometer). Urinary pH was measured with a pHmeter (Metrohm 
AG, Canada) and creatinine by a modified kinetic Jaffé colorimetric method 58. 
Urinary NH4+ was measured with the Berthelot protocol 59. Urine inorganic phosphate 
(Pi) concentration was determined by the phosphomolybdate method 60. 
 
Electron microscopy and immunogold labeling  
 Mice were anesthetized with 2.5 % Isoflurane/pressurized air and perfused 
through the left ventricle with PBS (0.9% NaCl in 10 mM phosphate buffer, pH 7.4) 
followed by paraformaldehyde-lysine-periodate fixative (PLP: 4% paraformaldehyde, 
75 mM lysine HCl, 10 mM sodium periodate, and 0.15 M sucrose in 37.5 mM sodium 
phosphate)61. After 5 minutes the kidneys were removed and postfixed for an 
additional hour on ice in the same fixative solution. Following fixation, the kidneys 
were stored at 4°C in PBS. 
 For immunogold staining, small pieces of Rhcg+/+ and -/- kidneys were 
dehydrated through a graded series of ethanol to 100% ethanol and then embedded 
in LR White resin (Electron Microscopy Sciences, Fort Washington, PA, USA). Thin 
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sections were incubated on drops of primary anti-H+-ATPase (A-subunit, 1:200) 
antibody for 2 h. After rinsing with PBS, the grids were incubated on drops of goat 
anti-rabbit IgG coupled to 15nm gold particles (Ted Pella, Redding, CA, USA) for 1 h. 
Following several rinses with distilled water, the grids were stained with 2% uranyl 
acetate for 10 min, rinsed in distilled water, and dried. Sections were examined in a 
JEM-1011 transmission electron microscope (JEOL Ltd, Tokyo, Japan).  
 
Immunohistochemistry  
 Rhcg+/+ and -/- mice were anesthetized with ketamine/xylazine and perfused 
through the left ventricle with PBS followed by paraformaldehyde-lysine-periodate 
(PLP) fixative 61. Kidneys were removed and fixed overnight at 4°C by immersion in 
PLP. Kidneys were washed three times with PBS, and 3 μm cryosections were cut 
after cryoprotection with 0.9 M sucrose in PBS for at least 1 h. Immunostaining was 
carried out as described 62. The following primary antibodies were used: guinea pig 
anti-AE1 1:500 63, rabbit anti-a4 H+-ATPase 1:500 33, rabbit anti-B1 H+-ATPase 33, 
rabbit anti-B2 H+-ATPase 1:500 64, mouse monoclonal ant E H+-ATPase 1:200 (gift 
from S. Gluck), rabbit anti Rhcg 65 1:1000 and goat anti AQP-2 (Santa Cruz 
Biotechnology) 1:1000. The secondary antibodies were donkey anti-rabbit 594, 
donkey anti-goat 488, donkey anti-rabbit 488, donkey anti-mouse 594 and donkey 
anti-guinea pig 647 (Molecular Probes) at 1:1000. 
 
Immunoblotting 
 Crude total membranes were obtained from Rhcg+/+ and -/- mouse renal 
medulla homogenized in 250 mM sucrose, 10 mM Tris-HCl, pH 7.5, and in the 
presence of protease inhibitors (Roche Protease Inhibitor Cocktail) 62. Fourty 
micrograms of crude membrane proteins were solubilized in Laemmli loading buffer 
containing 10% DTT and separated on 8 to 10% polyacrylamide gels. For 
immunoblotting, proteins were transferred electrophoretically to polyvinylidene 
fluoride membranes (Immobilon-P, Millipore Corp., Bedford, MA, USA). After blocking 
with 5 % milk powder in Tris-buffered saline/0.1% Tween-20 for 60 min, blots were 
incubated with primary antibodies: rabbit anti-mouse ATP6V1B1 (B1)(1:5000) 33, 
rabbit anti-ATP6V1B2 (B2) (1:5,000) 64, rabbit anti-ATP6V0a4 33, 1:5000, rabbit anti-
ATP6V0a1 (1:5000), a kind gift of Dr Xie, Dallas, TX, USA) 66, and mouse anti-
ATP6V1E2 (1:5000, a kind gift of Dr. S. L Gluck, University of California, San 
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Francisco, CA, USA) 67, and mouse monoclonal anti-β-actin antibody (Sigma, St. 
Louis, MO; 1:10000) overnight at 4°C. After washing and blocking with 5 % milk 
powder for 60 min, membranes were incubated for 2 h at room temperature with 
secondary goat anti-rabbit or donkey anti-mouse antibodies 1:5000 linked to alkaline 
phosphatase (Promega, Madison, WI, USA). The protein signal was detected with 
the appropriate substrate (Millipore Corp, Bedford, MA, USA) using the las-4000 
image analyzer system (Fujifilm Life Science USA). All images were analyzed using 
Advanced Image Data Analyzer AIDA (Raytest, Straubenhardt, Germany) to 
calculate the protein of interest/β-actin ratio. 
 
Cell culture 
 Non-transfected HEK293 (human embryonic kidney 293) or stably transfected 
with human RhCG (HEK-RhCG) cell lines were generated as previously described 6 
and grown at 37°C, 5% CO2 in DMEM (Dulbecco's modified Eagle's 
medium)/Glutamax I (Invitrogen) supplemented with 10% (v/v) fetal bovine serum. 
Selection of HEK-RhCG cells was performed in culture medium supplemented with 
0.3 mg/ml hygromycin (Invitrogen). For all pH experiments, cells were passaged, 
disseminated onto coverslips and grown to sub-confluency for 48 hours. The final 
medium exchange was performed 24 hours before the experiments were started. 
Medium pH was maintained at pH 7.4. 
 
RNA extraction and reverse transcription 
 Snap-frozen kidneys (five kidneys for each condition) or non-transfected HEK 
and HEK-RhCG cells (3 petri dishes of 5x106 cells for each condition) were 
homogenized in RLT-Buffer (Qiagen, Basel, Switzerland) supplemented with β-
mercaptoethanol to a final concentration of 1%. Total RNA was extracted from 200 μl 
aliquots of each homogenized sample using the RNeasy Mini Kit (Qiagen,Basel, 
Switzerland) according to the manufacturer’s instructions. Quality and concentration 
of the isolated RNA preparations were analyzed on the ND-1000 spectrophotometer 
(Nano-Drop Technologies). Total RNA samples were stored at −80°C. Each RNA 
sample was diluted to 100 ng/μl and 3 μl used as a template for reverse transcription 
using the TaqMan Reverse Transcription Kit (Applied Biosystems, Forster City, CA, 
USA). For reverse transcription, 300 ng of RNA template were diluted in a 40 μl 
reaction mix that contained (final concentrations) RT buffer (1 x), MgCl2 (5.5 mM), 
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random hexamers (2.5 μM), RNase inhibitor (0.4U/μl), the multiscribe reverse 
transcriptase enzyme (1.25U/μl), dNTP mix (500 μM each), and RNase-free water. 
 
Reverse Transcription and semiquantitative real-time PCR  
 Semiquantitative real-time RT-qPCR was performed on the ABI PRISM 7700 
Sequence Detection System (Applied Biosystems, Forster City, CA). Primers and 
probes were chosen using BLAST tool: Ensemble 
(http://www.ensembl.org/index.html) to result in amplicons no longer than 150 bp 
spanning intron-exon boundaries to exclude genomic DNA contamination. The 
specificity of all primers was first tested on mRNA derived from kidney and always 
resulted in a single product of the expected size (data not shown). Probes were 
labeled with the reporter dye FAM at the 5’ end and the quencher dye TAMRA at the 
3’ end (Microsynth, Balgach, Switzerland). Primers and probes sequences are 
summarized in supplementary table 3. 
 Real-Time PCR reactions were performed using TaqMan Universal PCR 
Master Mix (Applied Biosystems, Forster City, CA). Briefly, 3 μl cDNA, 0.8 μl of each 
primer (25 μM), 0.4 μl labeled probe (5 μM), 5 μl RNAse-free water, and 10 μl 
TaqMan Universal PCR Master Mix reached 20 μl of final reaction volume. Reaction 
conditions were denaturation at 95°C for 10 min followed by 40 cycles of 
denaturation at 95°C for 15s and annealing/elongation at 60°C for 60s with auto ramp 
time. All reactions were run in triplicate. For analyzing the data, the threshold was set 
to 0.2 as this value had been determined to be in the linear range of the amplification 
curves for all mRNAs in all experimental runs. The expression of the genes of interest 
was calculated in relation to hypoxanthine guanine phosphoribosyl transferase 
(mouse HPRT or human HPRT). Relative expression ratios were calculated as R = 
2(Ct(HPRT) − Ct(test gene), where Ct represents the cycle number at the threshold 0.02.  
 
Intracellular pH (pHi) measurements on HEK293 cells 
 For pHi measurements, individual slides seeded with non-transfected HEK or 
HEK-RhCG cells were transferred into a perfusion chamber (~ 3-5 ml/min flow rate) 
and mounted on an inverted microscope (Zeiss Axiovert 200, Carl Zeiss, Feldbach, 
Switzerland) equipped with a video imaging system (Visitron, Munich, Germany) for 
the duration of the experiment. The temperature of the chamber was maintained at 
37°C by an electronic feedback circuit. The control bath solution was initially a 
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HEPES-buffered Ringer solution (125 mM NaCl/ 5 mM KCl/ 1 mM CaCl2/ 1.2 mM 
MgSO4/ 2 mM NaH2PO4/ 32.2 mM HEPES/ 5 mM Glucose). Cells were loaded with 
the acetoxymethyl ester of the pH sensitive dye BCECF (10 µM, 2’,7’-bis(2-carboxyl)-
5-(and-6)-carboxyfluorescein, Invitrogen, Switzerland) for 15 min and washed to 
remove all non-deesterified dye. pHi was measured by microfluorometry by exciting 
the BCECF dye with a spot of light alternately at 490 and 440 nm while monitoring 
the emission at 532 nm with a video-imaging system 68. H+-ATPase activity was 
measured after induction of a sharp intracellular acidification using the NH4Cl (20 
mM) prepulse technique 32, 68. Bicarbonate-free solutions were used and Na+ was 
replaced by N-methyl-D-glucamine (NMDG). Each experiment was calibrated for pHi 
using the nigericin/high K+ method 69 and the obtained ratios were converted to pHi. 
Na+-independent pHi recovery rates in response to an acid load were calculated in 
non-transfected HEK293 and HEK293 stably transfected cells with RhCG. Data are 
shown as changes in pHi (ΔpHi) per minute. 
 
Microperfusion of isolated cortical collecting ducts 
 Male Rhcg+/+, Rhcg-/-, Atp6v1b1+/+, and Atp6v1b1-/- mice were given a HCl-
containing diet (a 50:75 mixture (w/V) of normal powdered chow, Kliba Nafag and 
0.33 M HCl) in normal cages for 2 days. Mice were anesthetized with 
Xylazin/Ketamin i.p. Both kidneys were cooled in situ with control bath solution (see 
below) for 1 min and then removed and cut into thin coronal slices for tubule 
dissection. Cortical CDs (CCDs) were dissected from the cortex at 10°C in the control 
solution under a stereo-microscope. 
 
Intracellular pHi measurement in microperfused cortical collecting ducts 
 The isolated tubules were transferred to the bath chamber on the stage of an 
inverted microscope (IX81, Olympus, Japan) in the control solution containing (in 
mM) 138 NaCl, 1.5 CaCl2, 1.2 MgSO4, 2 K2HPO4, 10 HEPES, 5.5 glucose, 5 alanine, 
pH 7.40) and then mounted on concentric pipettes and perfused in vitro with Na+-
free, ammonium-free solution where N-methyl-D-Glutamine+ (NMDG+) replaced Na+. 
The average tubule length exposed to bath fluid was limited to 300 – 350 µm in order 
to prevent motion of the tubule. CCDs were loaded with 5 µM of the fluorescent 
probe BCECF for ~20 min at 37°C in the control bath solution. Intracellular pH (pHi) 
recordings were made over regions of interest comprising of several cells, however, 
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the signal came mostly from intercalated cells that had taken up more BCECF-AM 
than principal cells. The loading solution was then washed out by initiation of bath 
flow and the tubule was equilibrated with dye-free control bath solution for 5 min. 
Bath solution was delivered at a rate of 20 ml/min and warmed to 37°C by water 
jacket immediately upstream to the chamber. After this temperature equilibration in 
control solution, tubules were first transiently acidified by peritubular Na+ removal 
(Na-free, ammonium-free solution) (10 min duration), replaced by NMDG+ to avoid 
exit of NH4+ by basolateral Na+-coupled transport. This maneuver was performed in 
the luminal absence of Na+. During the fluorescence recording, perfusion solution 
was delivered to the perfusion pipette via a chamber under an inert gas (N2) pressure 
(around 1 bar) connected through a manual 6-way valve. With this system, opening 
of the valve instantaneously activates flow of solutions. The majority of the fluid 
delivery to the pipette exits the rear of the pipette system through a drain port at 4 
ml/min. This method results in a smooth and complete exchange of the luminal or the 
peritubular solution in less than 3 to 4 s 70. After the fluorescence signal stabilization, 
luminal medium was instantly (at the rate of 4 ml/min in the draining) replaced by a 
Na+-free solution containing 20 mM NH4Cl (and 118 mM NMDG-Cl) that elicited a 
rapid intracellular alkalinization, followed by a sharp acidification. The rate of 
intracellular alkalinization has been associated with the entry of NH3 whereas the 
subsequent phase of intracellular acidification in the continued presence of 
extracellular NH4Cl reflects mostly NH4+ entry 12, 32. After the acidification reached a 
plateau, NH4Cl was removed from the lumen to further acidify cells and initiate direct 
H+-excretion with a maximum rate. All measurements were done at maximum rate for 
the determination of H+-ATPase activity. The measured light intensities were digitized 
with the CellM&CellR Imaging hardware system (Olympus, Japan) for further analysis 
as previously described 11-12, 53. For peritubular ammonium pulses, the peritubular 
solution was changed to a 6 mM NH4Cl solution, pH 7.40 in the presence of 1 mM 
furosemide and 2.5 mM ouabain in the bath. 
 
Intrinsic buffering capacity determination 
 The intrinsic buffering capacity (ßi) of CCD cells was determined for the Rhcg 
strain, as previously reported 11, 71, using a 40 mM NH4Cl basolateral pulse to acidify 
cells. To exclude HCO3-/CO2 as a buffering component and block Na+-dependent pHi 
regulatory mechanisms, Na+-free, HEPES-buffered solutions were used in perfusate 
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and bath containing 1 mM amiloride and bath and perfusate also contained 100 µM 
Sch28080 and 200 nM Concanamycin A. Addition of 40 mM NH4Cl to the bath 
induced an increase followed by a decrease in pHi. Cellular buffering power (βi) was 
measured in CCDs from Rhcg+/+ and Rhcg-/- mice.  
 
Statistics 
 Statistical comparisons were tested by unpaired t-test using Graphpad Prism 
(GraphPad Software). P values < 0.05 were considered as statistically significant. 
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FIGURE LEGENDS 
 
FIGURE 1. The B1 and B2 H+-ATPase subunits and Rhcg coexist in the same 
protein complex 
Co-Immunoprecipitation was performed on rat kidney medulla using crosslinking. 
Panel A: Co-IP was performed with anti-Rhcg (lane 2) and anti-B1 (lane 5) polyclonal 
antibodies or with an isotypic IgG antibody (lanes 1 and 4). Lanes 3 und 6 were 
loaded with 50 mg rat kidney medulla protein. Immunoblotting (IB) was performed 
against the B1 H+-ATPase subunit (left side) or against RhCG (right side). Panel B: 
the Co-IP membrane was stripped and reblotted with antibodies against Rhcg and B1 
H+-ATPase antibodies as control for the IP. The upper band for B1 (approx 70 kDa) is 
considered unspecific. Panel C: Co-IP was performed with anti-Rhcg (lane 2) and 
anti-B2 (lane 5) polyclonal antibodies or with an isotypic IgG antibody (lanes 1 and 4). 
Lanes 3 und 6 were loaded with 50 mg rat kidney medulla protein. Immunoblotting 
(IB) was performed against the B2 H+-ATPase subunit (left side) or against RhCG 
(right side). Panel D: the Co-IP membrane was stripped and reblotted with antibodies 
against Rhcg and B2 H+-ATPase antibodies as control for the IP. Panel E: 
Coimmunostaining of Rhcg and the E H+-ATPase subunit in kidney tissue from 
Rhcg+/+ and Rhcg-/- mice. Immunostaining of E H+-ATPase subunit (in red) and Rhcg 
(green) was performed on kidney sections from Rhcg+/+ and Rhcg-/- mice. Nucleus 
were labelled with DAPI staining. Inserts show higher magnification of single 
intercalated cells. 
 
 
 
FIGURE 2. H+ secretion is reduced in cortical collecting duct cells from Rhcg-/- 
mice.  
Cortical collecting ducts were isolated from kidneys of Rhcg+/+ and Rhcg-/- mice after 
2 days of HCl-loading, microperfused in vitro, and intracellular pH (pHi) monitored. 
NH4Cl (20 mM) was applied from the luminal perfusate. (A) Original pHi tracing from 
a CCD exposed to a luminal NH4Cl pulse. The arrow indicates the rate of pHi change 
measured and calculated. Exposure to an NH4Cl pulse caused a large intracellular 
acidification (not shown) followed by an alkalinization phase leading to pHi recovery. 
The initial slope (∆pHi/∆t) of the alkalinization phase was measured . (B) Bar graph 
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summarizing ∆pHi/∆t after removal of the luminal NH4Cl pulse (n = 8-12 
tubules/genotype). (C) Bar graph summarizing H+-fluxes calculated based on 
intracellular buffering power and pHi recovery rates. 
 
 
FIGURE 3. Increased B1 and decreased B2 H+-ATPase subunit abundance in 
Rhcg-/- mice. 
Protein expression of the B1 (A), B2 (B), E2 (C), a1 (D) and a4 (E) subunits of the 
H+-ATPase was assessed by Western blotting in medullary kidney tissue. In Rhcg-/- 
mice, B1-H+-ATPase protein abundance was upregulated (A), while B2 H+-ATPase 
was downregulated (B). Protein expression of the a1, a4, and E subunits remained 
unchanged (C-E). Values are mean ± SEM (n= 5 mice), ***p ≤ 0.001.  
 
FIGURE 4. Unchanged H+-ATPase subunit localization in Rhcg-/- type A 
intercalated cells.  
Immunostaining of B1, B2 and a4 subunits (in red) of three different H+-ATPase 
subunits (B1, B2, and a4) was performed on kidney sections from Rhcg+/+ and Rhcg-/- 
mice. Type A intercalated cells were identified by the presence of the anion 
exchanger AE1 (green) and principal cells using the apical water channel AQP2 (in 
blue). Inserts show higher magnification of single intercalated cells. 
 
FIGURE 5. Subcellular localization of H+-ATPases in type A intercalated cells is 
similar in Rhcg+/+ and Rhcg-/- mice. 
Immunogold staining for the A subunit of the H+-ATPase revealed a similar density of 
H+-ATPases at the apical membrane and in apically localized vesicles of type A 
intercalated cells in Rhcg+/+ (upper panels) and Rhcg-/- (lower panels) mice. 
Magnification of the boxed areas of the overview electron micrograph are shown on 
the right.  
 
FIGURE 6. Overexpression of RhCG in HEK293 cells stimulates ATP6V1B1 
expression. 
(A) HEK293 cells were left untransfected (HEK293-WT) or transfected to stably 
express RhCG (HEK293-RhCG) and RhCG expression was confirmed using RT-
qPCR. mRNA expression of ATP6V1B1 (B), ATP6V1B2 (C) and ATP6V0A1 (D) were 
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measured by RT-qPCR in HEK293-WT and RhCG overexpressing cells HEK293-
RhCG. ATP6V1B1 mRNA was higher in HEK293-RhCG cells versus HEK293-WT. 
The mRNA abundance of the other H+-ATPase subunits, ATP6V1B2 and ATP6V0A1, 
were unchanged. Values are mean ± SEM (n= 5 dishes), *p ≤ 0.05, *** ≤ 0.001 
 
FIGURE 7. RhCG overexpression in renal HEK293 cells increases H+ excretion. 
H+-ATPase activity was measured in non-transfected HEK293 cells (HEK293-WT) 
and HEK293 cells stably transfected with human RhCG (HEK293-RhCG) using the 
NH4Cl (20 mM) prepulse after loading cells with BCECF. (A) Original pHi tracings 
from WT) and RhCG overexpressing HEK293 cells. Dashed lines indicate the slope 
measured to calculate pHi changes over time.(B) Bar graph summarizes the H+ 
extrusion rate of HEK-WT compared to HEK-RhCG after NH4Cl pulse (n = 5 
cells/plate, 3 dishes/condition). Data are mean ± SEM, **p ≤ 0.01, 
 
FIGURE 8. Atp6v1b1-/- mice lacking the B1 H+-ATPase subunit have decreased 
H+-ATPase activity but preserved apical and basolateral NH3 permeabilities. 
Widltype (Atp6v1b1+/+) and Atp6v1b1-/- mice were observed in metabolic cages and 
urinary pH (A) and urinary ammonium excretion normalized to creatinine (B) 
monitored during baseline and an acid-load (HCl) for 4 days (n = 7/genotype). 
Cortical collecting ducts from mice acid-loaded for 2 days were microperfused in vitro 
and H+ secretion (C) and apical NH3 permeability (D) measured after a luminal NH4Cl 
prepulse (20 mM) (n = 10 tubules/genotype). (E) Similarly, basolateral NH3 
permeability assessed after an NH4Cl prepulse from the bath (6 mM) was not 
different between genotypes (n = 6 tubules/genotype). *p ≤ 0.05 
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SUPPLEMENTS 
 
Supplementary table 1. Blood values in C57Bl/6 mice and Atp6v1b1-/- mice 
under normal diet and HCl load for 4 days. Data are presented as mean ± SEM, n 
= 5-9 animals/ group, * p<0.05 vs baseline period in same genotype, # p<0.05 vs 
C57BL6 mice during the same period. 
 
Supplementary table 2. Body weight, food intake, and urinary values of C57BL6 
mice and Atp6v1b1-/- mice under normal diet and during an HCl load for 4 days. 
Data are presented as mean ± SEM, n = 5-9 animals/ group, * p<0.05 vs baseline 
period in same genotype, # p<0.05 vs C57BL6 mice during the same period. 
 
Supplementary table 3. Sequences of the primers and probes used for RT-
qPCR 
 
Supplementary figure 1. Unchanged mRNA expression of the B1, B2 and a4 
subunits of the H+-ATPase in Rhcg+/+ and Rhcg-/- mice.  
RT-qPCR was performed on total kidney to determine relative mRNA levels of 
several H+-ATPase relevant for intercalated cell H+-ATPase function. None of the 
mRNA values measured of the B1 (A), B2 (B) and a4 (C) isoforms was different 
between the 2 genotypes. Values are mean ± SEM (n= 5 mice). 
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SUPPLEMENTS 
 
Supplementary table 1. Blood values in C57Bl/6 mice and Atp6v1b1-/- mice under normal diet and HCl load for 4 days. Data 
are presented as mean ± SEM, n = 5-9 animals/ group, * p<0.05 vs baseline period in same genotype, # p<0.05 vs C57BL6 mice 
during the same period. 
 
Supplementary table 2. Body weight, food intake, and urinary values of C57BL6 mice and Atp6v1b1-/- mice under normal 
diet and during an HCl load for 4 days. Data are presented as mean ± SEM, n = 5-9 animals/ group, * p<0.05 vs baseline period 
in same genotype, # p<0.05 vs C57BL6 mice during the same period. 
 
Supplementary table 3. Sequences of the primers and probes used for RT-qPCR 
 
Supplementary figure 1. Unchanged mRNA expression of the B1, B2 and a4 subunits of the H+-ATPase in Rhcg+/+ and 
Rhcg-/- mice.  
RT-qPCR was performed on total kidney to determine relative mRNA levels of several H+-ATPase relevant for intercalated cell H+-
ATPase function. None of the mRNA values measured of the B1 (A), B2 (B) and a4 (C) isoforms were different between the 2 
genotypes. Values are mean ± SEM (n= 5 mice). 
  
Supplementary data 
Supplementary table 1. Blood values in  Atp6v1b1+/+ mice and Atp6v1b1-/- mice under normal diet and HCl load for 4 days 
  Basal status 2 days HCl 4 days HCl 
  
C57BL6 
(n=9) 
Atp6v1b1
-/-
 
(n=7) 
C57BL6 
(n=7) 
Atp6v1b1
-/-
 
(n=6) 
C57BL6 
(n=7) 
Atp6v1b1
-/-
 
(n=5) 
pH 7.35 ± 0.01 7.40 ± 0.01 7.11 ± 0.02* 7.15 ± 0.02* 7.24 ± 0.02 6.87 ± 0.12*# 
pCO2 (mmHg) 40.0 + 0.6 40.6 ± 1.2 37.3 ± 1.2 39.3 ± 1.5 39.4 ± 1.5 45.4 ± 2.5
#
 
HCO3 (mM) 21.6 + 0.7 24.8 ± 1.2 11.5 ± 0.8* 12.8 ± 0.6* 16.4 ± 0.9* 8.7 ± 1.8*
#
 
pO2 52.1 ± 2.2 48.8 ± 2.0 60.4 ± 2.4 62.6 ± 3.4 58.4 ± 2.5 83.8 ± 8.7*
#
 
Na
+
 (mM) 144.6 ± 0.5 145.4 ± 0.3 148.0 ± 1.1* 147.8 ± 1.5 151.4 + 0.5* 150.8 ± 2.4* 
Cl
-
 (mM) 109.7 ± 0.6 108.3 ± 0.7 123.4 ± 1.6* 121.0 ± 1.5* 120.0 ± 1.6* 133.6 ± 2.8*
#
 
Ca
2+
 (mM) 1.26 ± 0.01 1.23 ± 0.01 1.34 ± 0.01* 1.33 ± 0.02* 1.36 ± 0.02* 1.60 ± 0.1*
#
 
Hb (g/dl) 15.1 ± 0.2 15.7 ± 0.2 15.6 ± 0.3 16.7 ± 0.2*
#
 15.3 ± 0.2 18.8 ± 1.2*
#
 
 
* p<0.05 vs baseline period in same genotype, # p<0.05 vs Atp6v1b1+/+  mice during the same period. 
Supplementary table 2. Weight, food intake and urinary values in Atp6v1b1+/+ mice and Atp6v1b1-/- mice under normal diet 
and during an HCl load for 4 days 
 
Basal status 2 days HCl 4 days HCl 
C57BL6 
(n=7) 
Atp6v1b1
-/-
 
(n=7) 
C57BL6 
(n=7) 
Atp6v1b1
-/-
 
(n=7) 
C57BL6 
(n=7) 
Atp6v1b1
-/-
 
(n=5) 
Weight (g) 22.7 ± 0.28 28.1 ± 0.5
# 
20.4 ± 0.2* 24.6 ± 0.3*
#
 20.5 ± 0.3* 23.0 ± 0.3*
#
 
Weight lose in % of body weight under basal status 0.1 ± 0.6 0.4 ± 0.9 10.3 ± 0.5* 13.0 ± 1.6*
#
 11.9 ± 3.4* 18.8 ± 2.7*
#
 
Food intake (g/24hrs/body weight) 0.36 ± 0.01 0.36 ± 0.02 0.28 ± 0.01* 0.22 ± 0.03* 0.34 ± 0.04 0.26 ± 0.01*
#
 
Water intake (ml/24hrs/body weight) 0.17 ± 0.05 0.05 ± 0.01
#
 0.20 ± 0.05 0.20 ± 0.04* 0.18 ± 0.03 0.23 ± 0.06* 
Urine values       
volume (ml/24 h) 2.6 ± 0.4 3.0 ± 0.1 2.1 ± 0.2 4.7 ± 0.8
#
 3.1 ± 0.2 3.9 ± 1.2 
creatinine excretion (µmol/24 h) 3.7 ± 0.6 3.4 ± 0.2 3.4 ± 0.4 1.8 ± 0.3*
#
 1.9 ± 0.2* 1.9 ± 0.7* 
Urinary pH 6.2 ± 0.0 6.5 ± 0.1
#
 5.4 ± 0.1* 6.0 ± 0.0*
#
 5.7 ± 0.1* 6.0 ± 0.1*
#
 
UNH4/UCr (mEq/mmol) 3.4 ± 0.3 11.3 ± 1.2
#
 51.0 ± 2.0* 56.7 ± 13.8* 88.9 ± 6.2* 76.6 ± 7.2*
#
 
UPi/UCr (mEq/mmol) 13.1 ± 1.1 11.6 ± 0.7 14.3 ± 2.4 18.8 ± 3.2 16.4 ± 2.6 22.7 ± 5.2 
 
* p<0.05 vs baseline period in same genotype, # p<0.05 vs Atp6v1b1+/+ mice during the same period.  
 
 
 
 
 
 
 
Supplementary table 3. Primers and probes sequences of the gene expressions evaluated by RT-qPCR 
 
Gene Accession 
number 
Forward primer Reverse primer Probe 
Mouse 
Atp6v1b1 
NM_134157 5’-
CCCAGTATGCTGAGATTGTCAACTTTAC
CCTCC -3’ 
5’- 
CCTGAACAATGGCCTTGGTC-3’ 
5'-
CCCAGTATGCTGAGATTGTCAACTTTAC
CCTCC-3' 
Mouse 
Atp6v1b2 
NM_007509 5’- 
GCTGGTGATCCTGACGGACA TGAG-3’ 
5’-
CGTGCCGGTCGAGTGGAAGGTAGAAAC
GG-3’ 
5’- 
CTGCGAGAGGTTTCAGCTG-3’ 
Mouse 
Atp6V0a4 
NM_080467 5’- 
GACGGTGTCTCATCTATGGTTTGA-3’ 
5’- 
TTTGCCCTGCATGGTCTTGTC-3’ 
5'- 
TCTCTCCATTATCAAGAGCTCATGCCA -
3' 
Mouse Hprt NM_013556 5′-
TTATCAGACTGAAGAGCTACTGTAAGAT
C-3′ 
5′-
TTACCAGTGTCAATTATATCTTCAACAAT
C-3’ 
5'-
TGAGAGATCATCTCCACCAATAACTTTT
ATGTCCC-3' 
Human 
RhCG 
NM_016321 5’- CTACCGACGCAACCTAGAGC-3’ 5’-GCTGTCCCCATGGTAGGATA-3 5’-CTTTGCCATGATTGGCACCC-3’ 
Human 
ATP6V1B1 
NM_001692 5’-GAGATGATTCAGACGGGCATTT-3’ 5’-CTGGTGAAGAAGTCCAAGGC-3’ 5’-AATGAGATTGCCGCTCAGAT-3’ 
Human 
ATP6V1B2 
NM_001693 5’’-TGAAGGGACTTCAGGTATAGATGC-3’ 5’-GGAAGTCTTCGGCCAGTACA-3’ 5’-TGGTCGGGTATTCAATGGAT-3’ 
Human 
ATP6V0A1 
NM_001130020 5’-TTCCTGGAACTGACCGAATTA-3’ 5’-AGGAGTGCCTCTTCCCATCT-3’ 5’-GAGGCTGAATTGCATCATCA-3’ 
Human 
HPRT 
NM_000185 5’-AAGGGTGTTACGTTTAT-3’ 5’-TATTTCCTGTGCGTGAT-3’ 5'- ACCTCCTTGGGATCTATTTCACCG -3' 
 

